Lesina Blaz, Aburto María
Instituto de Hematología Rodolfo Virchow, Facultad de Medicina, Universidad Austral de Chile.
Rev Med Chil. 2005 Dec;133(12):1473-6. doi: 10.4067/s0034-98872005001200009. Epub 2006 Jan 27.
Since chylothorax is uncommon and has multiple causes, its best treatment choice is not clear. Recent reports show that octreotide is useful in the treatment of chylothorax secondary to cancer or caused by surgical procedures. We report a 21 years old male with a chylothorax secondary to a non Hodgkin lymphoma. Treatment with octreotide changed the color and triglyceride content of pleural effusion. Serum albumin and proteins increased and the effusion subsided after the second cycle of chemotherapy with CHOP. Thus octreotide was discontinued on the 27th day of therapy and pleural drainages were withdrawn. He was discharged in good conditions, 38 days after admission.
由于乳糜胸并不常见且病因多样，其最佳治疗选择尚不清楚。最近的报告显示，奥曲肽在治疗继发于癌症或手术引起的乳糜胸中有用。我们报告一名21岁男性，患有继发于非霍奇金淋巴瘤的乳糜胸。奥曲肽治疗改变了胸腔积液的颜色和甘油三酯含量。血清白蛋白和蛋白质增加，在CHOP方案化疗的第二个周期后胸腔积液消退。因此，在治疗第27天时停用奥曲肽并拔除胸腔引流管。入院38天后，他状况良好出院。
